Bostwick Laboratories receives major investment
- October 25, 2011
Bostwick Laboratories Inc. has received a majority investment by a New York-based private equity firm.
Bostwick, which is based in Glen Allen, is one of the largest privately owned anatomic pathology labs in the U.S. Metalmark Capital’s investment in Bostwick will provide capital needed for growth initiatives and to expand its pathology laboratory services, which include monitoring and diagnosis of cancer.
Terms of the deal were not disclosed.
Bostwick Founder and CEO Dr. David G. Bostwick will remain a major shareholder in the company.
“Metalmark’s knowledge of the sector, deep expertise in healthcare services and professional investment expertise made them the ideal partner to take Bostwick Laboratories to the next phase of growth,” Bostwick said in a statement.